MediPharm Labs Announces Closing of $75 Million Bought Deal Financing
The deal offers 13,514,000 common shares in the capital of the Company (“Common Shares”) at a price of $5.55 per Common Share.
Read More
Select Page
Posted by Invest In Weed | Jun 17, 2019
The deal offers 13,514,000 common shares in the capital of the Company (“Common Shares”) at a price of $5.55 per Common Share.
Read MorePosted by Invest In Weed | Jun 12, 2019
HEXO remains on-track ramping up to $400 million net revenue in fiscal 2020 and to double net...
Read MorePosted by Invest In Weed | Jun 10, 2019
Hexo to release its financial results for the third quarter fiscal 2019 ended April 30 after markets close on June 12, 2019.
Read MorePosted by Invest In Weed | Jun 3, 2019
Those who have been in this business for some time are aware of the sudden plunges of stocks at...
Read MorePosted by Invest In Weed | Jun 3, 2019
Sales have increased every quarter since Wildflower began selling its popular line of hemp CBD products.
Read MoreGet stock alerts, news & related alerts straight to your inbox!